Dennis L. Winger, Director at NEKTAR THERAPEUTICS (NKTR), sold 30,000 shares at $59.62 ($1.8M) on 2018-08-17, disclosed to the SEC on 2018-08-21.
Open-market sale of $1.8M NKTR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.62 | 15,000 | $894K | 49.7% |
| 2 | $60.30 | 15,000 | $905K | 50.3% |
| Total | $59.96 avg | 30,000 | $1.8M | 100% |
| Filing → |
| ARAY | BUY | 2013-03-05 | $86K | — | Filing → |
| NKTR | BUY | 2012-09-18 | $46K | — | Filing → |
| VRTX | BUY | 2010-02-18 | $251K | — | Filing → |